US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIMPLIFY PROPEL OPPORTUNITIES ETF

19.34

+0.01320.07%

Post-market: 19.34-0.0023-0.01%16:10 EDT

Volume:2K

Turnover:47.79K

Market Cap:82.98M

PE:- -

High:19.41

Open:19.41

Low:19.34

Close:19.33

52wk High:21.31

52wk Low:14.90

Shares:4.29M

Float Shares:4.29M

Volume Ratio:0.48

T/O Rate:0.06%

Dividend:2.72

Dividend Rate:14.07%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

BofA Securities Boosts Targets on Chinese CXO Players as Strong Biotech Funding Fuels R&D

Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/SURI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SURI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SURI\",,,,,undefined,":{"symbol":"SURI","market":"US","secType":"STK","nameCN":"SIMPLIFY PROPEL OPPORTUNITIES ETF","latestPrice":19.3423,"timestamp":1789761600000,"preClose":19.3291,"halted":0,"volume":2463,"hourTrading":{"tag":"盘后","latestPrice":19.34,"preClose":19.3423,"latestTime":"16:10 EDT","volume":7,"amount":135.3961,"timestamp":1789762204285,"change":-0.0023,"changeRate":-0.000119,"amplitude":0},"delay":0,"changeRate":0.0006829081540268927,"floatShares":4290001,"shares":4290001,"eps":0,"marketStatus":"Market Closed","change":0.0132,"latestTime":"09-18 16:00:00 EDT","open":19.41,"high":19.41,"low":19.34,"amount":47785,"amplitude":0.003621,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":19.3291,"sharesOutstanding":4520001,"nav":19.27,"aum":83427582.72,"dividendRate":0.14065,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":19.34,"preClose":19.3423,"latestTime":"16:10 EDT","volume":7,"amount":135.3961,"timestamp":1789762204285,"change":-0.0023,"changeRate":-0.000119,"amplitude":0},"volumeRatio":0.48411825590248064},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SURI\",,,,,undefined,":{"symbol":"SURI","floatShares":4290001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.48411825590248064,"shares":4290001,"dividePrice":2.7205,"high":19.41,"amplitude":0.003621,"preClose":19.3291,"low":19.34,"week52Low":14.9001,"pbRate":"--","week52High":21.31,"institutionHeld":0,"latestPrice":19.3423,"eps":0,"divideRate":0.14065,"volume":2463,"delay":0,"ttmEps":0,"open":19.41,"prevYearClose":16.675,"prevWeekClose":19.21,"prevMonthClose":20.1,"prevQuarterClose":17.895,"fiveDayClose":19.21,"twentyDayClose":19.859,"sixtyDayClose":17.2063},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SURI\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"SURI","amount":0.68,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"SURI","amount":0.68,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-09-25","symbol":"SURI","amount":0.68,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"SURI","amount":0.68,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-06-30"},{"date":"2025-03-26","symbol":"SURI","amount":0.68,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-03-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SURI\",market:\"US\",,,undefined,":[{"executeDate":"2023-03-27","recordDate":"2023-03-28","paymentDate":"2023-03-31","value":1,"currency":"USD"},{"executeDate":"2023-06-27","recordDate":"2023-06-28","paymentDate":"2023-07-03","value":0.68,"currency":"USD"},{"executeDate":"2023-09-27","recordDate":"2023-09-28","paymentDate":"2023-09-29","value":0.68,"currency":"USD"},{"executeDate":"2023-12-26","recordDate":"2023-12-27","paymentDate":"2023-12-29","value":0.68,"currency":"USD"},{"executeDate":"2024-03-25","recordDate":"2024-03-26","paymentDate":"2024-03-28","value":0.68,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SURI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SURI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","FXH","GNMX","IEIH","PJP","SURI","SBIO","FTXH","PBE","MRNY","PTH","RSPH","GNOM","BME","BIB","JHMH","IBBQ","PBPH","LFSC","MEDI","GDOC","LLYX","BBP","TBXU","MEDX","AZNH","PSCH","XPH","WDNA","SYNB","GSKH","APXH","MDTX","NVIB","GPCR","FBT","CURE","IBBJ","PINK","CNCR","BBH","MNTL","PSIL","IBRN","CANC","HYLG","JDOC","HRTS","FHLC","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","PINK","FBT","FTXH","FHLC","GSKH","IBRN","RSPH","MDTX","MEDI","IBBJ","PSIL","PBPH","PTH","GDOC","LENZ","GPCR","JDOC","JHMH","LFSC","AZNH","SYNB","PSCH","SBIO","MNTL","HYLG","FXH","MRNY","IBBQ","SURI","CNCR","WDNA","HRTS","TBXU","NVIB","GNMX","BIB","MEDX","XPH","GNOM","PJP","CURE","APXH","BME","PBE","IBB","IDNA","BBP","LLYX","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155684243","title":"BofA Securities Boosts Targets on Chinese CXO Players as Strong Biotech Funding Fuels R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1155684243","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155684243?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:50","pubTimestamp":1786596641,"startTime":"0","endTime":"0","summary":"BofA Securities has released a report indicating that the Chinese CXO sector is poised to benefit from robust biotech venture capital funding. The bank notes that strong financing in the first half...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125910500.SGD","SMCO","SURI","LU0700851271.USD","IBRN","LU2328871848.SGD","CXO","LU0348766576.USD","BK1141","LU1979443071.USD","LU1303224171.USD","BK1576","LU1997245177.USD","LU1997244956.HKD","LU1046422090.SGD","LU1808992512.USD","LU0348767384.USD","LU2495084118.USD","161027","PSCH","APXH","LU0611395673.USD","PSIL","LU1934453819.USD","BBC","LU0456842615.SGD","IE00B543WZ88.USD","LU2488822045.USD","FHLC","IDNA","LU0320764599.SGD","WX","02359","MEDI","IE00BPRC5H50.USD","LU1770034418.SGD","BK1583","LU1997245094.SGD","BK0216","LU0052750758.USD","LFSC","LU2045819591.USD","LU1719994722.HKD","LU1969619763.USD","LU0708995583.HKD","IE00B5MMRT66.SGD","LU1251922891.USD","BMED","XBIX","LU2242644610.SGD","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111112440","title":"Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=1111112440","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111112440?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:35","pubTimestamp":1786588544,"startTime":"0","endTime":"0","summary":"A report from Bank of America Securities indicates that Chinese CRO/CDMO companies are poised to benefit from robust first-half funding in the global and Chinese biotech sectors, along with active...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LU2125910500.SGD","IE00BPRC5H50.USD","XBIX","LU0359202008.SGD","LU1688375341.USD","BK1589","LU2242644610.SGD","LU1242518857.USD","LU2039709279.SGD","LU2045819591.USD","161027","BBC","LU1969619763.USD","LU1046422090.SGD","LU0051755006.USD","FHLC","BK1583","LU0348766576.USD","PSCH","LU1770034418.SGD","LU1794554557.SGD","LU0359201612.USD","LU0572944931.SGD","LU0856984785.SGD","LU2488822045.USD","LU0181495838.USD","PSIL","LU1242518931.SGD","LU0516423091.SGD","LU0708995583.HKD","LU0611395673.USD","IE00B543WZ88.USD","LU0052750758.USD","LU0039217434.USD","LU0043850808.USD","LU1997244956.HKD","603259","BK1610","LFSC","SG9999002562.SGD","SURI","BK1576","02359","LU0456846285.SGD","LU0348735423.USD","LU1880383366.USD","LU0348825331.USD","LU0140636845.USD","LU0516422440.USD","LU0823426308.USD","LU1251922891.USD","LU0417516902.SGD","WX","LU0516423174.USD","LU0029874061.USD","BK1521","LU1934453819.USD","SMCO","LU0348767384.USD","LU0516422366.SGD","LU2495084118.USD","LU0320764599.SGD","LU0700851271.USD","IDNA","LU2328871848.SGD","BK1141","LU0823426480.USD","LU0307460666.USD","LU0979878070.USD","LU1720050803.USD","LU0417516738.SGD","CXO","MEDI","LU0456842615.SGD","LU0516422952.EUR","IBRN","LU0819121731.USD","LU1979443071.USD","KURE","IE00B0JY6N72.USD","LU1808992512.USD","BMED","IE00B5MMRT66.SGD","LU0326950275.SGD","LU0588546209.SGD","LU1303224171.USD","LU1997245177.USD","SG9999002463.SGD","03759","LU1997245094.SGD","02269","BK0216","LU3063872942.SGD","LU0456827905.SGD","APXH","LU0327786744.USD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SURI\",params:#limit:6,delay:false,,,undefined,":[]}}